1 |
Bera, T. K., J. Viner, E. Brinkmann, and I. Pastan. 1999. Pharmacokinetics and antitumor activity of a bivalent disulfide-stabilized Fv immunotoxin with improved antigen binding to erbB2. Cancer Res. 59: 4018-4022
|
2 |
Buchner, J., I. Pastan, and U. Brinkmann. 1992. A method for increasing the yield of properly folded recombinant fusion proteins: Single-chain immunotoxins from renaturation of bacterial inclusion bodies. Anal. Biochem. 205: 263-270
DOI
ScienceOn
|
3 |
Kim, N. S., K. H. Chang, B. S. Chung, S. H. Kim, J. H. Kim, and G. M. Lee. 2003. Characterization of humanized antibody produced by apoptosis-resistant CHO cells under sodium butyrate-induced condition. J. Microbiol. Biotechnol. 13: 926-936
|
4 |
Kreitman, R. J., W. H. Wilson, K. Bergeron, M. Raggio, M. Stetler-Stevenson, D. J. FitzGerald, and I. Pastan. 2001. Efficacy of the anti-CD22 recombinant immunotoxin BL22 in chemotherapy-resistant hairy-cell leukemia. N. Engl. J. Med. 345: 241-247
DOI
ScienceOn
|
5 |
Kwak, B.-Y., B.-J. Kwon, C.-H. Kweon, and D.-H. Shon. 2004. Detection of Aspergillus, Penicillium, and Fusarium species by sandwich enzyme-linked immunosorbent assay using mixed monoclonal antibodies. J. Microbiol. Biotechnol. 14: 385-389
|
6 |
Lee, J.- W., I.-J. Jun, H. J. Kwun, K. L. Jang, and J. Cha. 2004. Direct identification of Vibrio vulnificus by PCR targeting elastase gene. J. Microbiol. Biotechnol. 14: 284-289
|
7 |
Pai, L. H., J. K. Batra, D. J. FitzGerald, M. C. Willingham, and I. Pastan. 1991. Anti-tumor activities of immunotoxins made of monoclonal antibody B3 and various forms of Pseudomonas exotoxin [published erratum appears in Proc. Natl. Acad. Sci. USA. 1991. 88: 5066]. Proc. Natl. Acad. Sci. USA 88: 3358-3362
|
8 |
Umetsu, M., K. Tsumoto, M. Hara, K. Ashish, S. Goda, T. Adschiri, and I. Kumagai. 2003. How additives influence the refolding of immunoglobulin-folded proteins in a stepwise dialysis system. Spectroscopic evidence for highly efficient refolding of a single-chain Fv fragment. J. Biol. Chem. 278: 8979-8987
DOI
ScienceOn
|
9 |
Bera, T. K. and I. Pastan. 1998. Comparison of recombinant immunotoxins against LeY antigen expressing tumor cells: Influence of affinity, size, and stability. Bioconjug. Chem. 9: 736-743
DOI
ScienceOn
|
10 |
Lev, A., H. Novak, D. Segal, and Y. Reiter. 2002. Recruitment of CTL activity by tumor-specific antibody-mediated targeting of single-chain class I MHC-peptide complexes. J. Immunol. 169: 2988-2996
DOI
|
11 |
Onda, M., Q. C. Wang, H. F. Guo, N. K. Cheung, and I. Pastan. 2004. In vitro and in vivo cytotoxic activities of recombinant immunotoxin 8H9(Fv)-PE38 against breast cancer, osteosarcoma, and neuroblastoma. Cancer Res. 15: 1419-1424
|
12 |
Reiter, Y., A. F. Wright, D. W. Tonge, and I. Pastan. 1996. Recombinant single-chain and disulfide-stabilized Fv immunotoxins that cause complete regression of a human colon cancer xenograft in nude mice. Int. J. Cancer 67: 113-123
DOI
ScienceOn
|
13 |
Studier, F. W. and B. A. Moffatt. 1986. Use of bacteriophage T7 polymerase to direct selective expression of cloned gene. J. Mol. BioI. 189: 113-130
DOI
|
14 |
Mansfield, E., I. Pastan, and D. J. FitzGerald. 1996. Characterization of RFB4-Pseudomonas exotoxin A immunotoxins targeted to CD22 on B-cell malignancies. Bioconjug. Chem. 7: 557-563
DOI
ScienceOn
|
15 |
Chaudhary, V. K., C. Queen, R. P. Junghans, T. A. Waldmann, D. J. FitzGerald, and I. Pastan. 1989. A recombinant immunotoxin consisting of two antibody variable domains fused to Pseudomonas exotoxin. Nature 339: 394-397
DOI
ScienceOn
|
16 |
Choi, S., J. Kim, Y. Lee, Y.-J. Jang, I. Pastan, and M. Choe. 2001. A divalent immunotoxin formed by the disulfide bond between hinge regions of Fab domain. Bull. Kor. Chem. Soc. 22: 1361-1365
|
17 |
Deonarain, M. P. and A. A. Epenetos. 1998. Design, characterization and anti-tumour cytotoxicity of a panel of recombinant, mammalian ribonuclease-based immunotoxins. Br. J. Cancer 77: 537 -546
DOI
ScienceOn
|
18 |
Kreitman, R. J., Q. C. Wang, D. J. FitzGerald, and I. Pastan. 1999. Complete regression of human B-cell lymphoma xenografts in mice treated with recombinant anti-CD22 immunotoxin RFB4(dsFv)-PE38 at doses tolerated by cynomolgus monkeys. Int. J. Cancer 81: 148-155
DOI
ScienceOn
|
19 |
Park, J. H., H. W. Kwon, H. K. Chung, I. H. Kim, K. Ahn, E. J. Choi, I. Pastan, and M. Choe. 2001. A divalent recombinant immunotoxin formed by a disulfide bond between the extension peptide chains. Mol. Cells 12: 398-402
|
20 |
Tur, M. K., M. Huhn, T. Thepen, M. Stocker, R. Krohn, S. Vogel, E. Jost, R. Osieka, J. G. van de Winkel, R. Fischer, R. Finnern, and S. Barth. 2003. Recombinant CD64-specific single chain immunotoxin exhibits specific cytotoxicity against acute myeloid leukemia cells. Cancer Res. 63: 8414-8419
|
21 |
Hudson, P. J. and A. A. Kortt. 1999. High avidity scFv multimers; diabodies and triabodies. J. Immunol. Methods 231: 177-189
DOI
ScienceOn
|
22 |
Jurado, P., D. Ritz, J. Beckwith, V. de Lorenzo, and L. A. Fernandez. 2002. Production of functional single-chain Fv antibodies in the cytoplasm of Escherichia coli. J. Mol. Biol. 320: 1-10
DOI
ScienceOn
|
23 |
Onda, M., S. Nagata, Y. Tsutsumi, J. J. Vincent, Q. Wang, R. J. Kreitman, B. Lee, and I. Pastan. 2001. Lowering the isoelectric point of the Fv portion of recombinant immunotoxins leads to decreased nonspecific animal toxicity without affecting antitumor activity. Cancer Res. 61: 5070-5077
|
24 |
Choe, M., K. O. Webber, and I. Pastan. 1994. B3(Fab)PE38M: A recombinant immunotoxin in which a mutant form of Pseudomonas exotoxin is fused to the Fab fragment of monoclonal antibody B3. Cancer Res. 54: 3460-3467
|
25 |
Kihara, A. and I. Pastan. 1995. Cytotoxic activity of chimeric toxins containing the epidermal growth factor-like domain of heregulins fused to PE38KDEL, a truncated recombinant form of Pseudomonas exotoxin. Cancer Res. 55: 71-77
|
26 |
Schmiedl, A., F. Breitling, and S. DubeI. 2000. Expression of a bispecific dsFv-dsFv' antibody fragment in Escherichia coli. Protein Eng. 13: 725-734
DOI
|
27 |
Kipriyanov, S. M., G. Moldenhauer, M. Braunagel, U. Reusch, B. Cochlovius, F. Le Gall, O. A. Kouprianova, C. W. Von der Lieth, and M. Little. 2003. Effect of domain order on the activity of bacterially produced bispecific single-chain Fv antibodies. J. Mol. Biol. 330: 99-111
DOI
ScienceOn
|
28 |
Jang, C. H., H. H. Chung, J. Yu, Y. J. Chang, H. B. Kim, S. H. Paek, D. H. Shin, and K. H. Kim. 1999. Single-chain Fv fragment of catalytic antibody 4f4f with glycosidase activity: Design, expression, and purification. J. Microbiol. Biotechnol. 9: 376-380
|
29 |
Shim, Y.-Y., D.-H. Shon, B.-Y. Kwak, J. Yu, and K.-M. Chee. 2004. Comparison of properties of poly clonal anti-Nacetylchitooligosaccharides and anti-chitooligosaccharides antibodies produced for ELISA. J. Microbiol. Biotechnol. 14: 686-692
과학기술학회마을
|
30 |
Baluna, R., E. Coleman, C. Jones, V. Ghetie, and E. S. Vitetta. 2000. The effect of a monoclonal antibody coupled to ricin A chain-derived peptides on endothelial cells in vitro: Insights into toxin-mediated vascular damage. Exp. Cell. Res. 258: 417-424
DOI
ScienceOn
|
31 |
Reiter, Y., U. Brinkmann, R. J. Kreitman, S. H. Jung, B. Lee, and I. Pastan. 1994. Stabilization of the Fv fragments in recombinant immunotoxins by disulfide bonds engineered into conserved framework regions. Biochemistry 33: 5451-5459
DOI
ScienceOn
|
32 |
Lim, H.-K., S.-U. Lee, S.-I. Chung, K.-H. Jung, and J.-H. Seo. 2004. Induction of the T7 promoter using lactose for production of recombinant plasminogen Kringle 1-3 in Escherichia coli. J. Microbiol. Biotechnol. 14: 225-230
|